Atlas Trials

Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder

Clinical trial NCT05850689 · RECRUITING

Trial details

NCT number
NCT05850689
Sponsor
Intra-Cellular Therapies, Inc.
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Major Depressive Disorder
Start date
2023-05-02
Primary completion
2027-04-05
Enrollment
470

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.